Andrei Nikonov, the founder of NextGenRnD, has a PhD in Virology (Molecular and Cell Biology curriculum). His work was primarily associated with two University of Tartu laboratories — DNA viruses laboratory and RNA viruses laboratory. The former laboratory produced Icosagen and Quattromed HTI, which is currently known as SYNLAB. The latter laboratory together with Valneva SE created the IXCHIQ® Chikungunya vaccine (currently authorized for use in the European Union and Canada).
Andrei has been crafting and licensing innovative solutions to multidisciplinary R&D problems (Challenges) since 2016. His solutions outcompeted hundreds of other solution proposals in the global open innovation marketplace.
NextGenRnD was founded to offer unparalleled R&D solutions to multidisciplinary problems encountered in chemistry, biotechnology, pharmaceutical industry, life sciences, food, agriculture, animal and human health.
NextGenRnD offers advisory services to help our clients solve their challenges. Be it research and development project or grant proposal, technology reverse or forward engineering. We are passionate about making technology and biotechnology projects happen.
It is by logic that we prove, but by intuition that we discover